US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.
The market research available can provide investors and analysts credible information on the direction of pharmaceuticals, anesthesia, drug delivery, pricing, regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction.
  • Biopharmaceuticals (221)
  • Diseases & Conditions (4421)
  • Drug Delivery (185)
  • Therapeutic Area (7004)
  • Vaccines (643)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Cardiac Rhythm Management Device Markets
5/1/2015 | published by: Kalorama Information
... particularly arrhythmias and congestive heart failure. This report,  C ardiac Rhythm Device Markets,  includes cardiac rhythm management devices with both external and internal applications.  Major segments include defibrillators: electrical devices that deliver therapeutic levels of ...  |  read more...
USD 3,995
Fallopian Tube Cancer-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fallopian Tube Cancer Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Familial Chylomicronemia (Type I Hyperlipoproteinemia)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Familial Chylomicronemia (Type I Hyperlipoproteinemia) Report helps to identify emerging players with potentially strong product information ...  |  read more...
USD 1,250
Fatty Liver Disease-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fatty Liver Disease Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Heat Shock Protein (Hsp) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Heat Shock Protein (Hsp) Inhibitors Report helps to identify emerging players with potentially strong product ...  |  read more...
USD 1,250
Febrile Neutropenia-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Febrile Neutropenia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Febrile Neutropenia- Pipeline ...  |  read more...
USD 1,250
Fecal Incontinence-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Fecal Incontinence Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Fecal Incontinence- Pipeline ...  |  read more...
USD 1,250
Heat Shock Protein 27 (Hsp27) Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (Hsp27) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Heat Shock Protein 27 (Hsp27) Inhibitors Report helps to identify emerging players ...  |  read more...
USD 1,250
Female Infertility-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Female Infertility Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Female Infertility- Pipeline ...  |  read more...
USD 1,250
Hedgehog Signaling Pathway Antagonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hedgehog Signaling Pathway Antagonists Report helps to identify emerging players with potentially strong product information and create effective ...  |  read more...
USD 1,250
Fever-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Fever Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Fever- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Fibromyalgia-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Fibromyalgia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Fibromyalgia- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Fistula-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Fistula Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Fistula- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Food Allergy-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Food Allergy Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Food Allergy- Pipeline ...  |  read more...
USD 1,250
Fracture-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Fracture Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Fracture- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Friedreich Ataxia-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Friedreich Ataxia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Friedreich Ataxia- Pipeline ...  |  read more...
USD 1,250
Fungemia-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Fungemia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Fungemia- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Gastrointestinal Bleeding-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Gastrointestinal Bleeding Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Gastrointestinal Bleeding- Pipeline ...  |  read more...
USD 1,250
Gastrointestinal Tract Cancer-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Gastrointestinal Tract Cancer Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Gastroparesis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Gastroparesis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Gastroparesis- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Generalized Seizures-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Generalized Seizures Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Generalized Seizures- Pipeline ...  |  read more...
USD 1,250
Genital Herpes-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Genital Herpes Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Genital Herpes- Pipeline ...  |  read more...
USD 1,250
Gingivitis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Gingivitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Gingivitis- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Hepatitis C Virus (HCV) Protease Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Protease Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hepatitis C Virus (HCV) Protease Inhibitors Report helps to identify emerging players ...  |  read more...
USD 1,250
Gliosarcoma-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Gliosarcoma Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Gliosarcoma- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
< prev 1    3  4  5  6  7  8  9  10